Article
Mutation detection in plasmid-based biopharmaceuticals.
Biotechnology journal - 1 Apr 2011
Oliveira Pedro H, Prather Kristala L J, Prazeres Duarte M F, Monteiro Gabriel A
Abstract excerpt
As the number of applications involving therapeutic plasmid DNA (pDNA) increases worldwide, there is a growing concern over maintaining rigorous quality control through a panel of high-quality assays. For this reason, efficient, cost-effective and sensitive technologies enabling the identification of genetic variants and unwanted side products are needed to successfully establish the identity and stability of a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.